ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05205	Proteoglycans in cancer	2/5	271/7206	0.0130696443863
ko00531	Glycosaminoglycan degradation	1/5	23/7206	0.0158617477506
ko05219	Bladder cancer	1/5	48/7206	0.032873823512
ko05321	Inflammatory bowel disease (IBD)	1/5	56/7206	0.0382677097406
ko05200	Pathways in cancer	2/5	492/7206	0.0405153581773
ko05213	Endometrial cancer	1/5	62/7206	0.0422973087953
ko05221	Acute myeloid leukemia	1/5	63/7206	0.0429675934336
ko05223	Non-small cell lung cancer	1/5	66/7206	0.0449761958675
ko04214	Apoptosis - fly	1/5	72/7206	0.0489832832535